<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.1.189">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>BS4014: Molecular Basis of Diseases - 5&nbsp; Anti-Ras Drugs</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
</style>


<script src="../site_libs/quarto-nav/quarto-nav.js"></script>
<script src="../site_libs/quarto-nav/headroom.min.js"></script>
<script src="../site_libs/clipboard/clipboard.min.js"></script>
<script src="../site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="../site_libs/quarto-search/fuse.min.js"></script>
<script src="../site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="../">
<link href="../chapters/week6.html" rel="next">
<link href="../chapters/week4.html" rel="prev">
<script src="../site_libs/quarto-html/quarto.js"></script>
<script src="../site_libs/quarto-html/popper.min.js"></script>
<script src="../site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="../site_libs/quarto-html/anchor.min.js"></script>
<link href="../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="../site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="../site_libs/bootstrap/bootstrap.min.js"></script>
<link href="../site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="../site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="../site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>
<script async="" src="https://hypothes.is/embed.js"></script>

  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Anti-Ras Drugs</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="../">BS4014: Molecular Basis of Diseases</a> 
        <div class="sidebar-tools-main tools-wide">
    <a href="https://github.com/kevfo/BS4014_Notes" title="Source Code" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="" title="Share" id="sidebar-tool-dropdown-0" class="sidebar-tool dropdown-toggle px-1" data-bs-toggle="dropdown" aria-expanded="false"><i class="bi bi-share"></i></a>
    <ul class="dropdown-menu" aria-labelledby="sidebar-tool-dropdown-0">
        <li>
          <a class="dropdown-item sidebar-tools-main-item" href="https://twitter.com/intent/tweet?url=|url|">
            <i class="bi bi-bi-twitter pe-1"></i>
          Twitter
          </a>
        </li>
        <li>
          <a class="dropdown-item sidebar-tools-main-item" href="https://www.facebook.com/sharer/sharer.php?u=|url|">
            <i class="bi bi-bi-facebook pe-1"></i>
          Facebook
          </a>
        </li>
    </ul>
  <a href="" class="quarto-color-scheme-toggle sidebar-tool" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
  <a href="" class="quarto-reader-toggle sidebar-tool" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
</div>
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true"><strong>PART I: LECTURE NOTES</strong></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week1.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Course Concepts Overview</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week2.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Origin of Cancer and Proto-Oncogenes</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week3.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Tumor Suppressor Gene Retinoblastoma (Rb)</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week4.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Cancer Cell Metabolism</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week5.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Anti-Ras Drugs</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week6.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">The p53 Protein</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week7.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Amyloids and TTR</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../chapters/week8.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Alzheimer’s Disease</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true"><strong>PART II: TUTORIALS</strong></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../tutorials/week2.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Origins of Cancer, Oncogenes, and Tumor Suppressor Genes</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../tutorials/week3.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Retinoblastoma and Cancer Cell Metabolism</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../tutorials/week4.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Oncometabolites, Ras, and IDH</span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#a-little-about-ras" id="toc-a-little-about-ras" class="nav-link active" data-scroll-target="#a-little-about-ras"><span class="toc-section-number">5.1</span>  A Little About Ras</a>
  <ul class="collapse">
  <li><a href="#ras-cannot-be-targeted" id="toc-ras-cannot-be-targeted" class="nav-link" data-scroll-target="#ras-cannot-be-targeted"><span class="toc-section-number">5.1.1</span>  Ras Cannot be Targeted</a></li>
  <li><a href="#ftase-inhibitors" id="toc-ftase-inhibitors" class="nav-link" data-scroll-target="#ftase-inhibitors"><span class="toc-section-number">5.1.2</span>  Ftase Inhibitors</a></li>
  </ul></li>
  <li><a href="#inhibiting-ras-activity" id="toc-inhibiting-ras-activity" class="nav-link" data-scroll-target="#inhibiting-ras-activity"><span class="toc-section-number">5.2</span>  Inhibiting Ras Activity</a>
  <ul class="collapse">
  <li><a href="#interference-with-nucleotide-binding" id="toc-interference-with-nucleotide-binding" class="nav-link" data-scroll-target="#interference-with-nucleotide-binding"><span class="toc-section-number">5.2.1</span>  Interference with Nucleotide Binding</a></li>
  <li><a href="#irreversible-covalent-modification" id="toc-irreversible-covalent-modification" class="nav-link" data-scroll-target="#irreversible-covalent-modification"><span class="toc-section-number">5.2.2</span>  Irreversible Covalent Modification</a></li>
  <li><a href="#stopping-gtpase-gef-interactions" id="toc-stopping-gtpase-gef-interactions" class="nav-link" data-scroll-target="#stopping-gtpase-gef-interactions"><span class="toc-section-number">5.2.3</span>  Stopping GTPase-GEF Interactions</a></li>
  <li><a href="#inhibiting-gtpase-effector-interactions" id="toc-inhibiting-gtpase-effector-interactions" class="nav-link" data-scroll-target="#inhibiting-gtpase-effector-interactions"><span class="toc-section-number">5.2.4</span>  Inhibiting GTPase-Effector Interactions</a></li>
  <li><a href="#stabilizing-gtpase-protein-complexes" id="toc-stabilizing-gtpase-protein-complexes" class="nav-link" data-scroll-target="#stabilizing-gtpase-protein-complexes"><span class="toc-section-number">5.2.5</span>  Stabilizing GTPase-Protein Complexes</a></li>
  </ul></li>
  <li><a href="#drug-targets" id="toc-drug-targets" class="nav-link" data-scroll-target="#drug-targets"><span class="toc-section-number">5.3</span>  Drug Targets</a>
  <ul class="collapse">
  <li><a href="#drug-resistance" id="toc-drug-resistance" class="nav-link" data-scroll-target="#drug-resistance"><span class="toc-section-number">5.3.1</span>  Drug Resistance</a></li>
  </ul></li>
  </ul>
<div class="toc-actions"><div><i class="bi bi-github"></i></div><div class="action-links"><p><a href="https://github.com/kevfo/BS4014_Notes/edit/main/chapters/week5.qmd" class="toc-action">Edit this page</a></p><p><a href="https://github.com/kevfo/BS4014_Notes/issues/new" class="toc-action">Report an issue</a></p></div></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title d-none d-lg-block"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Anti-Ras Drugs</span></h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<p>The <a href="week1.html#rascycle">first week’s lecture</a> has already covered how Ras behaves in the cell - including how it goes into the nucleus.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/ras.png" class="img-fluid figure-img" width="620"></p>
<p></p><figcaption class="figure-caption">Different Confromations of the Ras Enzyme in its GTP-Bound Form</figcaption><p></p>
</figure>
</div>
</div>
</div>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/ras2.png" class="img-fluid figure-img" width="628"></p>
<p></p><figcaption class="figure-caption">Different Confromations of the Ras Enzyme</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>The Ras enzyme has different shapes (i.e., conformations) depending on whether or not it is active or inactive.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/rasbind.png" class="img-fluid figure-img" width="614"></p>
<p></p><figcaption class="figure-caption">Ras Binding to the SOS Protein</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>As previously noted, Ras binds to a protein called <strong>SOS</strong> (i.e., short for <strong>s</strong>on <strong>o</strong>f <strong>s</strong>evenless), and when it does, its overall shape is pretty similar to that of it when it binds to GTP if you don’t account for the Mg<sup>2+</sup> ion and the stuff that happens in the P-loop.</p>
<p>In the above graphic, the SOS protein is found within a region called the <strong>H loop</strong>, and this controls the exchanging.</p>
<section id="a-little-about-ras" class="level2" data-number="5.1">
<h2 data-number="5.1" class="anchored" data-anchor-id="a-little-about-ras"><span class="header-section-number">5.1</span> A Little About Ras</h2>
<p>Scientists figured out that when small proteins called <strong>GTPases</strong> were activated, this caused diseases no thanks to the signalling effects that these GTPases have.</p>
<p>As of now, scientists know of three ways that these activations can happen:</p>
<ol type="1">
<li>Increased GEF activity (i.e., a kinase) may keep the GTPases active for a long, long time.</li>
<li>The GTPases’ genes may be mutated, so this makes it so that the proteins themselves cannot be hydrolyzed or inactivated.</li>
<li>The GAP protein - which typically removes the phosphate groups and inactivates the GTPases - is unable to do its job.</li>
</ol>
<section id="ras-cannot-be-targeted" class="level3" data-number="5.1.1">
<h3 data-number="5.1.1" class="anchored" data-anchor-id="ras-cannot-be-targeted"><span class="header-section-number">5.1.1</span> Ras Cannot be Targeted</h3>
<p>However, scientists think that Ras is one of those proteins that cannot be targeted. Ras is almost like a sort of criminal mastermind that evades the police’s attention for these couple of reasons:</p>
<ol type="1">
<li>Ras has a smooth surface. It doesn’t have many pockets where a molecule can bind tightly to.</li>
<li>Small GTPase proteins don’t have spaces (i.e., cavities) for small molecules to bind to.</li>
<li>GTPases communicate via something called <strong>p</strong>rotein <strong>p</strong>rotein <strong>i</strong>nteractions (i.e., <strong>PPIs</strong>), and current approaches aren’t really good at preventing PPIs from happening.</li>
</ol>
<p>Because of this, the current inhibitors that we have to prevent Ras from doing its thing have looked at targeting upstream and downstream events like the Ras-MEK-ERK pathway. Scientists also look at compounds that can mess up how Ras is organized.</p>
</section>
<section id="ftase-inhibitors" class="level3" data-number="5.1.2">
<h3 data-number="5.1.2" class="anchored" data-anchor-id="ftase-inhibitors"><span class="header-section-number">5.1.2</span> Ftase Inhibitors</h3>
<p>In the past, scientists though that inhibiting <strong>Ftase</strong> - the enzyme that attaches farnesyl pyrophosphate onto the C-end of Ras and stabilizes it in the cell’s membrane would be an incredibly promising way to go about inhibting Ras. But, when they tried to put this into practice (i.e., clinical trials), they found out that this idea didn’t work so well because Ras can also be stabilized in the membrane by another kind of enzyme: <strong>geranylgeranyl transferases</strong>.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/catalytic.png" class="img-fluid figure-img" width="280"></p>
<p></p><figcaption class="figure-caption">Catalytic Domain of the Ras Protein</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Although we don’t really know much about the membrane that Ras binds to, we do know that a part of it called the <strong>catalytic domain</strong> is in contact with the membrane.</p>
<p>These domains have a lot of something called cholesterol, and the “switch” region shown in the above graphic can have all sorts of conformations that scientists thing could play roles in various functions. That said, there are two kinds of conformations in GTP-bound Ras proteins.</p>
<p><strong>State 1</strong> of the Ras protein is a version of Ras that doesn’t have interactions between a Mg<sup>2+</sup> ion and amino acids. The state also doesn’t bind to effector proteins all that well.</p>
</section>
</section>
<section id="inhibiting-ras-activity" class="level2" data-number="5.2">
<h2 data-number="5.2" class="anchored" data-anchor-id="inhibiting-ras-activity"><span class="header-section-number">5.2</span> Inhibiting Ras Activity</h2>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/inhibit.png" class="img-fluid figure-img" width="408"></p>
<p></p><figcaption class="figure-caption">Strategies to Inhibit Ras Activity</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>The above graphic shows some plausible ways that the Ras enzyme can be inhibited.</p>
<section id="interference-with-nucleotide-binding" class="level3" data-number="5.2.1">
<h3 data-number="5.2.1" class="anchored" data-anchor-id="interference-with-nucleotide-binding"><span class="header-section-number">5.2.1</span> Interference with Nucleotide Binding</h3>
<p>If Ras cannot switch between its active and its inactive states, then it cannot become activated.</p>
<p>However, there’s a big, big problem with this: the GTP molecule doesn’t really bind to Ras with that high of an affinity (i.e., the two molecules don’t bind together that strongly as well).</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/cdc.png" class="img-fluid figure-img" width="296"></p>
<p></p><figcaption class="figure-caption">Small Molecules Inhibiting Cdc42</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Scientists have found out that small molecules can bind to GTPase called <strong>Cdc42</strong>, and it’s these molecules that can affect Ras’ conversion from its inactive to its active state.</p>
</section>
<section id="irreversible-covalent-modification" class="level3" data-number="5.2.2">
<h3 data-number="5.2.2" class="anchored" data-anchor-id="irreversible-covalent-modification"><span class="header-section-number">5.2.2</span> Irreversible Covalent Modification</h3>
<p>When Ras has something called a <strong>K-Ras activating mutation</strong> in its G12C location, we can target the Ras enzyme by irreversibly attaching inhibitors to Ras’ active site.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/binding.png" class="img-fluid figure-img" width="321"></p>
<p></p><figcaption class="figure-caption">Irreversibly Attaching Inhibitors to a Mutated Ras</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Luckily for us, it turns out that this is the most common kind of mutation in Ras when it comes to lung cancer. About 7% all lung cancer tumors have this kind of mutation.</p>
</section>
<section id="stopping-gtpase-gef-interactions" class="level3" data-number="5.2.3">
<h3 data-number="5.2.3" class="anchored" data-anchor-id="stopping-gtpase-gef-interactions"><span class="header-section-number">5.2.3</span> Stopping GTPase-GEF Interactions</h3>
<p>The problem with using small molecules to inhibit Ras itself is that it also has to compete with the GEF protein. And even if the molecule in question was able to compete with GEF, it probably wouldn’t do well in the grand scheme of protein-protein interactions</p>
<p>On top of that, we could also try to use protein inhibitors instead of just small molecules. They may have higher specificities, but there are three main problems with this approach:</p>
<ol type="1">
<li>It may take a lot of time, money, and resources to make such a protein</li>
<li>The protein could just be degraded by the body’s enzymes</li>
<li>If the protein is too big, it might not be able to cross to certain areas like the blood-brain barrier.</li>
</ol>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/rassos.png" class="img-fluid figure-img" width="263"></p>
<p></p><figcaption class="figure-caption">The SOS Protein Binding to Ras</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>In the above PyMOL visualization, we see that there is an alpha helix that belongs to the SOS protein - the protein is also facing the Ras protein. The red regions and the amino acid positions suggest that that part of SOS interacts with the Ras protein.</p>
<section id="peptide-inhibitors" class="level4" data-number="5.2.3.1">
<h4 data-number="5.2.3.1" class="anchored" data-anchor-id="peptide-inhibitors"><span class="header-section-number">5.2.3.1</span> Peptide Inhibitors</h4>
<p>One way we could go about stopping SOS (i.e., a GEF that activates Ras) is by making a replica (i.e., surrogate) of the SOS protein’s <span class="math inline">\(\alpha\)</span>-helix.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/alpha_helix.png" class="img-fluid figure-img" width="654"></p>
<p></p><figcaption class="figure-caption">Changes to Ras Binding From Alpha-Helix Primary Sequence</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>As we can see, the original <span class="math inline">\(\alpha\)</span>-helix isn’t that folded nor does it dissolve in water all that well. Certain amino acid changes in the primary sequence of this helix can improve its structure and also its activity.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/mimics.png" class="img-fluid figure-img" width="663"></p>
<p></p><figcaption class="figure-caption">Procedure for Making an Alpha-Helix Surrogate</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>The way we usually go about making these <span class="math inline">\(\alpha\)</span>-helix variants is that we use chemistry and two reagents called <strong>4-pentanoic acid</strong> and <strong>N-allyl glycine</strong> to make the covalent bonds between every three or four amino acids. The bond has has the following structure: C-triple bond-C-C-N.</p>
<section id="raw-data" class="level5" data-number="5.2.3.1.1">
<h5 data-number="5.2.3.1.1" class="anchored" data-anchor-id="raw-data"><span class="header-section-number">5.2.3.1.1</span> Raw Data</h5>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/bindings.png" class="img-fluid figure-img" width="676"></p>
<p></p><figcaption class="figure-caption">Binding Affinities for Different Helices</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>In the above graphs, we have three different helices: <span class="math inline">\(\alpha\)</span>H2, HBS2, and HBS3. Nonetheless, the HBS3 helix’s affinity for the Ras-GDP complex is about ten times lower than that of the SOS protein’s.</p>
<p>HBS3 messes up the job of SOS when it comes to swapping out molecules in a test tube. It also makes a process called <strong>ERK activation</strong> slower in HeLa cells when they don’t have enough nutrients.</p>
</section>
</section>
<section id="hydrocarbon-staples" class="level4" data-number="5.2.3.2">
<h4 data-number="5.2.3.2" class="anchored" data-anchor-id="hydrocarbon-staples"><span class="header-section-number">5.2.3.2</span> Hydrocarbon Staples</h4>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/staples.png" class="img-fluid figure-img" width="622"></p>
<p></p><figcaption class="figure-caption">Hydrocarbon Staple Schematics</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Something else that we can do to make better <span class="math inline">\(\alpha\)</span>-helices is that we can also use peptides that are called <strong>hydrocarbon staples</strong>.</p>
<p>What we’re essentially doing here is that we use different hydrocarbons (i.e., compounds that only have carbons and hydrogens on them) to link various amino acids (usually those four to seven residues apart).</p>
<p>A chemical reaction called the <strong>RCM reaction</strong> is used to make this happen.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/kras.png" class="img-fluid figure-img" width="662"></p>
<p></p><figcaption class="figure-caption">Raw, Experimental Data From Hydrocarbon Staple Peptides</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>The above figure shows some raw data as they pertain to different alpha helices with different hydrocarbon staples put onto them. These helices were all examined in the site of the Ras protein (i.e., with the GEF protein next to them).</p>
<p>What we can see is that the a, c, and d helices all exhibit some sort of effect on the Kras mutant of the Ras protein (i.e., the “Kras” refers to the specific type of a Ras protein).</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/helix_bindings.png" class="img-fluid figure-img" width="558"></p>
<p></p><figcaption class="figure-caption">Hydrocarbon Staple Helices</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Indeed - different hydrocarbon staple peptides have different affinities for for the Kras binding pocket.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/raw1.png" class="img-fluid figure-img" width="584"></p>
<p></p><figcaption class="figure-caption">Raw Data of Hydrocarbon Staple Helices</figcaption><p></p>
</figure>
</div>
</div>
</div>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/raw2.png" class="img-fluid figure-img" width="570"></p>
<p></p><figcaption class="figure-caption">Raw Data of Hydrocarbon Staple Helices</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Of one these helices in particular is SAH-SOS1_A_. This peptides helps inhibit Ras signalling effects in cancer patients whose cells have the G12D mutant of Ras.</p>
</section>
</section>
<section id="inhibiting-gtpase-effector-interactions" class="level3" data-number="5.2.4">
<h3 data-number="5.2.4" class="anchored" data-anchor-id="inhibiting-gtpase-effector-interactions"><span class="header-section-number">5.2.4</span> Inhibiting GTPase-Effector Interactions</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/fbpk12.png" class="img-fluid figure-img" width="604"></p>
<p></p><figcaption class="figure-caption">FBPK12 Chaperon Protein Information</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>In our cells, there’s a protein called <strong>FBPK12</strong> that pretty much just binds to other proteins.</p>
<p>If we have - say - a <strong>bifunctional peptide</strong> or a protein with two different sequences or domains (i.e., regions), what can happen is that this bifunctional peptide would bind to FBPK12 and also Ras</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/states.png" class="img-fluid figure-img" width="608"></p>
<p></p><figcaption class="figure-caption">Ras Conformational States</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>One cool thing to note about Ras is that it has two different states in this context:</p>
<ol type="1">
<li><p><strong>State 1</strong></p>
<p>This state really likes to bind to GTP, but not so much the proteins that are involved in signalling later down the road. This state also has binding pockets that reduces signalling by binding to Ras.</p></li>
<li><p><strong>State 2</strong></p>
<p>The second state pretty much just wants to bind to effector proteins (i.e., once Ras is activated).</p></li>
</ol>
</section>
<section id="stabilizing-gtpase-protein-complexes" class="level3" data-number="5.2.5">
<h3 data-number="5.2.5" class="anchored" data-anchor-id="stabilizing-gtpase-protein-complexes"><span class="header-section-number">5.2.5</span> Stabilizing GTPase-Protein Complexes</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/protein.png" class="img-fluid figure-img" width="268"></p>
<p></p><figcaption class="figure-caption">Ras Conformational States</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>When Ras forms numerous complexes with other proteins, this may lead to the creation of new binding sites that we can then target using drug molecules. These same drugs can also stabilize the complexes.</p>
<p>As an examplee, the above compounds all bind to Ras - we know this because of this thing called <strong>screening</strong>. Compount 46 binds to site A of Ras while compounds 47 and 48 bind to site B of Ras.</p>
<p>The binding of these compounds then cause Ras to be reorganized and for the Cys118 residue to be exposed. This subsequently allows compound 49 to bind to that residue.</p>
</section>
</section>
<section id="drug-targets" class="level2" data-number="5.3">
<h2 data-number="5.3" class="anchored" data-anchor-id="drug-targets"><span class="header-section-number">5.3</span> Drug Targets</h2>
<p>The generation of this thing called <strong>N5, N10-methylene-THF</strong> involves a reaction cycle. In the context of cancer cells, there is a crucial need for a continuous and rapid supply of <strong>dTMP</strong> to support DNA synthesis. Inhibiting the enzymes involved in this pathway can be a potential strategy to kill cancer cells. Two specific enzymes, <strong>Thymidylate Synthase (TS)</strong> and <strong>Dihydrofolate Reductase (DHFR)</strong>, are targeted by anticancer drugs.</p>
<p>One of these drugs is <strong>FdUMP</strong>, which is a fluorinated analog of dUMP. It functions as an irreversible inhibitor of TS. FdUMP acts as a “suicide substrate,” effectively locking TS into a ternary complex with itself and <strong>tetrahydrofolate (THF)</strong>.</p>
<p>On the other hand, drugs designed to target DHFR are analogs of dihydrofolate (DHF). These compounds, often referred to as <strong>anti-folate drugs</strong>, have a significantly higher affinity for DHFR, binding to it with a thousandfold greater affinity.</p>
<section id="drug-resistance" class="level3" data-number="5.3.1">
<h3 data-number="5.3.1" class="anchored" data-anchor-id="drug-resistance"><span class="header-section-number">5.3.1</span> Drug Resistance</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="../imgs/week5/cancer_cells.png" class="img-fluid figure-img" width="640"></p>
<p></p><figcaption class="figure-caption">Cancer Cells and Drugs</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Cancer cells are tricky because they have a lot of mutations, which means they’re not all the same. This makes it hard to kill all of them with just one medicine. Also, they can change and become resistant to the drugs we use against them.</p>
<p>Some cancer cells have something called <strong>Multi-drug Resistance</strong>, or <strong>MDR</strong>. This happens because they have too many copies of a gene called Mdr1, which makes a special protein that helps them pump drugs out of the cells. So, if we use one drug to treat these cells, they not only become resistant to that drug but also to others they haven’t seen before.</p>
<p>There are proteins that work like pumps, pushing drugs out of the cells. And sometimes, the gene that makes <strong>DHFR</strong> (another protein) can become too many in the cells. When there’s too much DHFR, the cancer cells don’t respond well to certain drugs called <strong>antifolates</strong>.</p>
<p>To fight cancer effectively, we often use multiple drugs together because this makes it harder for the cancer cells to become resistant. So, it’s like attacking them from different angles to make sure we can beat them.</p>


</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
    // Hack to workaround the fact that safari doesn't
    // properly recolor the scrollbar when toggling (#1455)
    if (navigator.userAgent.indexOf('Safari') > 0 && navigator.userAgent.indexOf('Chrome') == -1) {
      manageTransitions("body", false);
      window.scrollTo(0, 1);
      setTimeout(() => {
        window.scrollTo(0, 0);
        manageTransitions("body", true);
      }, 40);  
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  let localAlternateSentinel = 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } 
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="../chapters/week4.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Cancer Cell Metabolism</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="../chapters/week6.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">The p53 Protein</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>